Aging
Navigate
Back to articleFigure 5(5 of 6)
100%
Figure 5
Figure 5.Prognostic nomograms with or without FPR for predicting survival of mCRC patient. (a) nomogram including FPR for predicting 3 years’ PFS; (b) nomogram without FPR for predicting 3 years’ PFS; (c) nomogram including FPR for predicting 3 years’ OS; (d) nomogram without FPR for predicting 3 years’ OS.
Figure 5 — Elevated FPR confers to radiochemoresistance and predicts clinical efficacy and outcome of metastatic colorectal cancer patients | Aging